Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a southwestern region of Germany
- 86 Downloads
Methicillin-resistant Staphylococcus aureus (MRSA) has developed into an important human pathogen and is increasingly being found to be the cause of skin and soft tissue infections or invasive infections in many communities. We have determined the prevalence of MRSA among S. aureus isolates from pediatric in- and outpatients of the University Children’s Hospital of Freiburg, from children attending primary care pediatricians and from healthy children entering school in a prospective study carried out in a southwestern region of Germany. Of the healthy children tested, all between 5 and 7 years of age, 25.8% were intra-nasally colonized with S. aureus. A total of 1455 S. aureus isolates were tested for antibiotic susceptibility. Apart from penicillin resistance (82.1%), an overall high susceptibility of S. aureus to antibiotics, including clindamycin, was common, while resistance among the S. aureus isolates to erythromycin and clindamycin had even significantly decreased from 2002 to 2004. Methicillin-resistance was exceedingly rare (0.3%).
In the southwestern region of Germany, about one quarter of the healthy children tested at school entry were found to be colonized with S. aureus. The prevalence of MRSA among healthy as well as hospitalized children colonized with S. aureus is still extremely rare in this region.
KeywordsStaphylococcus aureus Children Germany MRSA Prevalence
Community-acquired methicillin-resistant Staphylococcus aureus
Hospital-acquired methicillin-resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus
The study was supported by BMBF grant no. 01KI0215 from the Federal Ministry of Education and Research, Germany, to the network PID-ARI.net.
The authors thank Dr. Christian Bogdan (Department of Microbiology and Hygiene, Institute for Medical Microbiology and Hygiene, University Hospital Freiburg) for his critical review of the manuscript.
- 4.Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, Ahmad N, McCracken GH Jr, Appelbaum PC (2005) Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 49:2283–2288PubMedCrossRefGoogle Scholar
- 7.Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Bradley JS (2004) Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Eur J Clin Microbiol Infect Dis 23:445–455PubMedCrossRefGoogle Scholar
- 9.Linde H, Wagenlehner F, Strommenger B, Drubel I, Tanzer J, Reischl U, Raab U, Holler C, Naber KG, Witte W, Hanses F, Salzberger B, Lehn N (2005) Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis 24:419–422PubMedCrossRefGoogle Scholar
- 12.National Committee on Clinical Laboratory Standards (2004) Performance standards for antimicrobial disk susceptibility testing. Clinical and Laboratory Satndards Institute, 14th informational supplement. NCCLS document M100-S14, Wayne, PaGoogle Scholar
- 13.Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H, European Antimicrobial Resistance Surveillance System Participants (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 10:1627–1634PubMedGoogle Scholar